Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("MEPHENYTOINE")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 154

  • Page / 7
Export

Selection :

  • and

LYMPHANGIOGRAPHIC FINDINGS OF MESANTOIN-INDUCED PSEUDOLYMPHOMA = RESULTATS DE LA LYMPHANGIOGRAPHIE DANS LE PSEUDOLYMPHOME PROVOQUE PAR LA MESANTOINESAYOC AS; HOWLAND WJ.1974; RADIOLOGY; U.S.A.; DA. 1974; VOL. 111; NO 3; PP. 579-580; BIBL. 7REF.Article

Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in manKUPFER, A; PREISIG, R.European journal of clinical pharmacology. 1984, Vol 26, Num 6, pp 753-759, issn 0031-6970Article

STEREOSELECTIVE METABOLISM OF MEPHENYTOIN IN MANKUEPFER A; SCHENKER S; ROBERTS RK et al.1981; J. PHARMACOL. EXP. THER.; ISSN 0022-3565; USA; DA. 1981; VOL. 218; NO 1; PP. 193-199; BIBL. 32 REF.Article

EVIDENCE FOR THE EPOXIDE-DIOL PATHWAY IN THE BIOTRANSFORMATION OF MEPHENYTOINGERBER N; THOMPSON RM; SMITH RG et al.1979; EPILEPSIA; USA; DA. 1979; VOL. 20; NO 3; PP. 287-294; ABS. FRE/SPA/GER; BIBL. 19 REF.Article

UEBER EIN NEUES PHOTOMETRISCHES VERFAHREN ZUR BESTIMMUNG VON MEPHENYTOIN. = UN NOUVEAU PROCEDE PHOTOMETRIQUE POUR LA DETERMINATION DE LA MEPHENYTOINESTAJER G; SZABO AE; VINKLER E et al.1978; PHARMAZIE; DTSCH.; DA. 1978; VOL. 33; NO 2-3; PP. 126-127; BIBL. 6 REF.Article

ANTICONVULSIVANT ET MODIFICATION DE L'HEMATOPOIESE CHEZ L'ENFANTCAP J; MISIKOVA Z.1975; BRATISLAV. LEKARSKE LISTY; CESKOSL.; DA. 1975; VOL. 64; NO 1; PP. 95-100; ABS. RUSSE ANGL. ALLEM.; BIBL. 17 REF.Article

CLINICAL PHARMACOLOGY OF MEPHENYTOIN AND ETHOTOINTROUPIN AS; FRIEL P; LOVELY MP et al.1979; ANN. NEUROL.; USA; DA. 1979; VOL. 6; NO 5; PP. 410-414; BIBL. 11 REF.Article

High-performance liquid chromatographic determination of urinary 4'-hydroxymephenytoin, a metabolic marker for the hepatic enzyme CYP2C19, in humansHONG-GUANG XIE; SONG-LIN HUANG; HONG-HAO ZHOU et al.Journal of chromatography. B, Biomedical applications. 1995, Vol 668, Num 1, pp 125-131Article

High-throughput radiometric CYP2C19 inhibition assay using tritiated (S)-mephenytoinDI MARCO, Annalise; CELLUCCI, Antonella; CHAUDHARY, Ashok et al.Drug metabolism and disposition. 2007, Vol 35, Num 10, pp 1737-1743, issn 0090-9556, 7 p.Article

Mephenytoin overdose: Phenytoin poisoning incognito? Case report and mephenytoin/phenytoin comparisonBUCHWALD, Alan L.Journal of toxicology. Clinical toxicology. 2000, Vol 38, Num 7, pp 781-785, issn 0731-3810Article

Analysis of cell death inducing compoundsSPICKER, Jeppe S; PEDERSEN, Henrik Toft; NIELSEN, Henrik Bjørn et al.Archives of toxicology. 2007, Vol 81, Num 11, pp 803-811, issn 0340-5761, 9 p.Article

STEREOSELECTIVITY OF DIFFERENTIAL ROUTES OF DRUG METABOLISM. THE FATE OF THE ENANTIOMERS OF (14C) MEPHENYTOIN IN THE DOGKUPFER A; BIRCHER J.1979; J. PHARMACOL. EXPER. THERAPEUT.; USA; DA. 1979; VOL. 209; NO 2; PP. 190-195; BIBL. 28 REF.Article

PARADOXICAL INTOXICATION. A COMPLICATION OF ANTICONVULSANT ADMINISTRATION.TROUPIN AS; OJEMANN LM.1975; EPILEPSIA; U.S.A.; DA. 1975 PARU 1976; VOL. 16; NO 5; PP. 753-758; ABS. FR. ESP. ALLEM.; BIBL. 19 REF.Article

NITRIERUNGSPRODUKTE EINIGER PHENYLSUBSTITUIERTER ANTICONVULSIVA = PRODUITS DE NITRATION DE QUELQUES ANTICONVULSIVANTS PHENYLSUBSTITUESWIEGREBE W; WEHRHAHN L; SCHLUNEGGER UP et al.1975; PHARM. ACTA HELV.; SUISSE; DA. 1975; VOL. 50; NO 9; PP. 261-268; BIBL. 21 REF.Article

Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populationsALVAN, G; BECHTEL, P; ISELIUS, L et al.European journal of clinical pharmacology. 1990, Vol 39, Num 6, pp 533-537, issn 0031-6970, 5 p.Article

Family studies of mephenytoin hydroxylation deficiencyINABA, T; JURIMA, M; KALOW, W et al.American journal of human genetics. 1986, Vol 38, Num 5, pp 768-772, issn 0002-9297Article

Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphismWEDLUND, P. J; ASLANIAN, W. S; MACALLISTER, C. B et al.Clinical pharmacology and therapeutics. 1984, Vol 36, Num 6, pp 773-780, issn 0009-9236Article

Two single-tube tetra-primer assays to detect the CYP2C19*2 and *3 alleles of S-mephenytoin hydroxylaseHERSBERGER, Martin; MARTI-JAUN, Jacqueline; RENTSCH, Katharina et al.Clinical chemistry (Baltimore, Md.). 2001, Vol 47, Num 4, pp 772-774, issn 0009-9147Article

Assessment of cytochrome P450 activity by a five-drug cocktail approachBING ZHU; OU-YANG, Dong-Sheng; CHEN, Xiao-Ping et al.Clinical pharmacology and therapeutics. 2001, Vol 70, Num 5, pp 455-461, issn 0009-9236Article

Allelic, genotypic and phenotypic distributions of S-mephenytoin 4'-hydroxylase (CYP2C19) in healthy Caucasian populations of European descent throughout the worldXIE, H.-G; STEIN, C. M; KIM, R. B et al.Pharmacogenetics (London). 1999, Vol 9, Num 5, pp 539-549, issn 0960-314XArticle

Debrisoquine and S-mephenytoin hydroxylation phenotypes and genotypes in a Korean populationROH, H.-K; DAHL, M.-L; JOHANSSON, I et al.Pharmacogenetics (London). 1996, Vol 6, Num 5, pp 441-447, issn 0960-314XArticle

Rapid screening for polymorphisms in dextromethorphan and mephenytoin metabolismGUTTENDORF, R. J; BRITTO, M; BLOUIN, R. A et al.British journal of clinical pharmacology. 1990, Vol 29, Num 4, pp 373-380, issn 0306-5251Article

Mephenytoin and sparteine pharmacogenetics in Canadian CaucasiansINABA, T; JURIMA, M; NAKANO, M et al.Clinical pharmacology and therapeutics. 1984, Vol 36, Num 5, pp 670-676, issn 0009-9236Article

GAS-CHROMATOGRAPHIC DETERMINATION OF MEPHENYTOIN AND DEMETHYLMEPHENYTOIN, AFTER COLUMN ALKYLATIONRAISYS VA; ZEBELMAN AM; MCMILLAN SF et al.1979; CLIN. CHEM.; USA; DA. 1979; VOL. 25; NO 1; PP. 172-175; BIBL. 16 REF.Article

Comparison of (S)-mephenytoin and proguanil oxidation in vitro : Contribution of several CYP isoformsCOILER, J. K; SOMOGYI, A. A; BOCHNER, F et al.British journal of clinical pharmacology. 1999, Vol 48, Num 2, pp 158-167, issn 0306-5251Article

  • Page / 7